ALNY vs. AGX
ALNY (Alnylam Pharmaceuticals, Inc.) and AGX (Argan, Inc.) are both stocks. ALNY operates in Biotechnology (Healthcare), while AGX operates in Engineering & Construction (Industrials). Over the past 10 years, ALNY returned 18.16%/yr vs 37.51%/yr for AGX. At a 0.17 correlation, their price movements are largely independent.
Performance
ALNY vs. AGX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ALNY achieves a -27.53% return, which is significantly lower than AGX's 135.64% return. Over the past 10 years, ALNY has underperformed AGX with an annualized return of 18.16%, while AGX has yielded a comparatively higher 37.51% annualized return.
ALNY
- 1D
- 0.62%
- 1M
- -3.12%
- YTD
- -27.53%
- 6M
- -27.72%
- 1Y
- -7.97%
- 3Y*
- 14.36%
- 5Y*
- 10.66%
- 10Y*
- 18.16%
AGX
- 1D
- -6.74%
- 1M
- 12.25%
- YTD
- 135.64%
- 6M
- 121.56%
- 1Y
- 255.33%
- 3Y*
- 170.89%
- 5Y*
- 75.91%
- 10Y*
- 37.51%
ALNY vs. AGX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ALNY Alnylam Pharmaceuticals, Inc. | -27.53% | 68.99% | 22.94% | -19.46% | 40.14% | 30.48% | 12.85% | 57.96% | -42.61% | 239.34% |
AGX Argan, Inc. | 135.64% | 130.61% | 198.31% | 30.24% | -2.01% | -11.64% | 19.15% | 8.62% | -14.32% | -34.26% |
Correlation
The correlation between ALNY and AGX is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.15 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.12 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.15 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.14 |
Correlation (All Time) Calculated using the full available price history since Jun 1, 2004 | 0.17 |
Fundamentals
ALNY:
$39.83B
AGX:
$10.46B
ALNY:
$4.26
AGX:
$11.38
ALNY:
67.59
AGX:
64.71
ALNY:
9.10
AGX:
10.02
ALNY:
37.04
AGX:
22.09
ALNY:
$4.29B
AGX:
$1.04B
ALNY:
$2.51B
AGX:
$217.93M
ALNY:
$729.86M
AGX:
$163.99M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ALNY vs. AGX — Risk / Return Rank
ALNY
AGX
ALNY vs. AGX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Alnylam Pharmaceuticals, Inc. (ALNY) and Argan, Inc. (AGX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ALNY | AGX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.65 | ||
| Sortino ratioReturn per unit of downside risk | -3.78 | ||
| Omega ratioGain probability vs. loss probability | 0.99 | 1.47 | -0.48 |
| Calmar ratioReturn relative to maximum drawdown | -0.18 | 10.30 | -10.49 |
| Martin ratioReturn relative to average drawdown | -0.32 | 29.33 | -29.65 |
Loading charts...
Drawdowns
ALNY vs. AGX - Drawdown Comparison
The maximum ALNY drawdown since its inception was -83.58%, smaller than the maximum AGX drawdown of -94.37%. Use the drawdown chart below to compare losses from any high point for ALNY and AGX.
Loading charts...
Drawdown Indicators
| ALNY | AGX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -83.58% | -94.37% | +10.79% |
Max Drawdown (1Y)Largest decline over 1 year | -43.39% | -24.96% | -18.43% |
Max Drawdown (3Y)Largest decline over 3 years | -43.39% | -43.75% | +0.36% |
Max Drawdown (5Y)Largest decline over 5 years | -43.39% | -43.75% | +0.36% |
Max Drawdown (10Y)Largest decline over 10 years | -59.95% | -54.61% | -5.34% |
Current DrawdownCurrent decline from peak | -41.33% | -6.74% | -34.59% |
Average DrawdownAverage peak-to-trough decline | -30.61% | -48.30% | +17.69% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 24.66% | 8.75% | +15.91% |
Volatility
ALNY vs. AGX - Volatility Comparison
The current volatility for Alnylam Pharmaceuticals, Inc. (ALNY) is 9.83%, while Argan, Inc. (AGX) has a volatility of 20.17%. This indicates that ALNY experiences smaller price fluctuations and is considered to be less risky than AGX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ALNY | AGX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.83% | 20.17% | -10.34% |
Volatility (6M)Calculated over the trailing 6-month period | 25.55% | 54.86% | -29.31% |
Volatility (1Y)Calculated over the trailing 1-year period | 37.11% | 74.89% | -37.78% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 48.86% | 51.29% | -2.43% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 53.63% | 46.04% | +7.59% |
Dividends
ALNY vs. AGX - Dividend Comparison
ALNY has not paid dividends to shareholders, while AGX's dividend yield for the trailing twelve months is around 0.25%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AGX Argan, Inc. | 0.25% | 0.52% | 0.93% | 2.24% | 2.71% | 1.94% | 7.31% | 2.49% | 1.98% | 4.44% | 1.42% | 2.16% |
ALNY Alnylam Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
ALNY vs. AGX - Financials Comparison
This section allows you to compare key financial metrics between Alnylam Pharmaceuticals, Inc. and Argan, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ALNY vs. AGX - Profitability Comparison
ALNY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Alnylam Pharmaceuticals, Inc. reported a gross profit of 0.00 and revenue of 1.17B. Therefore, the gross margin over that period was 0.0%.
AGX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Argan, Inc. reported a gross profit of 61.11M and revenue of 290.95M. Therefore, the gross margin over that period was 21.0%.
ALNY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Alnylam Pharmaceuticals, Inc. reported an operating income of 268.64M and revenue of 1.17B, resulting in an operating margin of 23.0%.
AGX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Argan, Inc. reported an operating income of 45.40M and revenue of 290.95M, resulting in an operating margin of 15.6%.
ALNY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Alnylam Pharmaceuticals, Inc. reported a net income of 205.99M and revenue of 1.17B, resulting in a net margin of 17.7%.
AGX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Argan, Inc. reported a net income of 46.06M and revenue of 290.95M, resulting in a net margin of 15.8%.
Frequently Asked Questions
ALNY and AGX have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AGX has higher volatility (20.17%) compared to ALNY (9.83%). In terms of maximum drawdown, ALNY dropped -83.58% vs AGX's -94.37%.
AGX currently has the higher Sharpe Ratio (3.43 vs -0.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ALNY and AGX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer